Related Tags >> Avastin Amgen pipeline FDA approval

Velcade News

Most Popular Velcade Story

ASCO already churning out news

May 30, 2008 — 11:06am ET | By Tracy Staton

Today marks the start of the annual American Society of Clinical Oncology meeting, always a big news generator in the pharma biz. We'll let our sister pub FierceBiotech keep you up to date on the... Read more...

Velcade Press Releases

VELCADE Approved Across all Disease Stages for Broad Spectrum of Patients
The NEJM Publishes Millennium's Phase III Results of VELCADE (Bortezomib) for Injection in Previously Untreated Multiple Myeloma
PRESS RELEASE: Phase III Trial of VELCADE for Injection Showed Dramatic Fourfold Increase in Complete Remission Rates
PRESS RELEASE: Phase III Trial in Multiple Myeloma Stopped Early Due to Significant Efficacy Advantage of VELCADE

Latest Headlines

ASCO already churning out news
May 30, 2008
Takeda risks short-term pain in buyout
April 25, 2008
Takeda offers $8.8B for Millennium
April 10, 2008
ALSO NOTED: Takeda prevails in Actos patent suit; Analyst gets peek at Biovail founder's laptop;
April 4, 2008
ALSO NOTED: Merck agrees to extended deadline; Millennium disputes IMS data on Velcade;
March 26, 2008
Specialty-drug spending spawns protest
March 20, 2008
ALSO NOTED: Allergan to close Irish plant, lay off 300; FDA grants quick review to Velcade use;
January 30, 2008
ALSO NOTED: Did Merck, Schering withhold Zetia data?;Genentech gives eye docs access to Avastin
December 21, 2007
Analysts tag Velcade as blockbuster
December 10, 2007
ALSO NOTED: New drug approval lags in 2007; Velcade boosts Millenium Pharma's outlook;
November 2, 2007
UK accepts J&J's money-back guarantee
October 25, 2007

Paid Research Reports